PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients

F. Kleiburg*, L. F. de Geus-Oei, S. A.C. Luelmo, R. Spijkerman, J. J. Goeman, F. A.J. Toonen, F. Smit, T. van der Hulle, L. Heijmen

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

124 Downloads (Pure)

Fingerprint

Dive into the research topics of 'PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Medicine and Dentistry